Key facts
- Basil Systems’s last known valuation is $25.0M (Apr 2025).
- It has raised $11.3M across 1 recorded rounds; the latest was Seed Round ($4.8M) in Dec 2021.
- Notable investors include Alumni Ventures, Service Provider Capital, Golden Ventures, Hearst Ventures, Argosy Capital — 11 tracked in total.
- Basil Systems has filed 2 Form Ds with the SEC since 2021, most recently Nov 2023 ($4.8M sold to 13 investors).
- Status: Privately Held (backing).
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 11 names
- ·Watchlist + deal alerts for Basil Systems
Funding rounds
1 roundsAbout Basil Systems
Developer of an AI-powered product, market, and clinical intelligence platform designed to access the vital insights that drive medical product development success. The company's platform provides new analytics and insights that guide strategic product development decisions, improve product and supply chain quality, mitigate product recall risks, and reduce regulatory approval times, enabling companies to deliver safe products to consumers.
- Sector
- Information Technology
- HQ
- Boston, MA, United States
- Founded
- 2019
- Employees
- 23
- Website
- basilsystems.com/
- Ownership
- Privately Held (backing)
Basil Systems doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Basil Systems shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Basil Systems in its N-PORT filings yet. We sweep new filings monthly.